ELV · Company KPIs
Elevance Health (ELV) KPIs
Total Medical Membership, Benefit Expense Ratio, Days in Claims Payable, CarelonRx Quarterly Adjusted Scripts. As reported in SEC filings, with the source line for each figure.
Total Medical Membership
44.88M at Sep 30, 2026
The filings read for this page do not define this measure.
| Period ended | Figure | Filing text |
|---|---|---|
| Sep 30, 2026 | 44.88M | Total Medical Membership · 44,882 · 45,369 · 44,949 · (1.1)% · (0.1)%8-K filed 2026-10-21 |
| Jun 30, 2026 | 44.95M | Total Medical Membership · 44,949 · 45,621 · 45,418 · (1.5)% · (1.0)%8-K filed 2026-07-15 |
| Mar 31, 2026 | 45.42M | Total Medical Membership · 45,418 · 45,833 · 45,232 · (0.9)% · 0.4%8-K filed 2026-04-22 |
| Dec 31, 2025 | 45.23M | Total Medical Membership · 45,232 · 45,734 · 45,369 · (1.1%) · (0.3%)8-K filed 2026-01-28 |
| Sep 30, 2025 | 45.37M | Total Medical Membership · 45,369 · 45,760 · 45,621 · (0.9) % · (0.6) %8-K filed 2025-10-21 |
| Jun 30, 2025 | 45.62M | Total Medical Membership · 45,369 · 45,760 · 45,621 · (0.9) % · (0.6) %8-K filed 2025-10-21 |
| Mar 31, 2025 | 45.83M | Total Medical Membership · 45,418 · 45,833 · 45,232 · (0.9)% · 0.4%8-K filed 2026-04-22 |
| Dec 31, 2024 | 45.73M | Total Medical Membership · 45,232 · 45,734 · 45,369 · (1.1%) · (0.3%)8-K filed 2026-01-28 |
Benefit Expense Ratio
90.6% for the period ended Sep 30, 2026
The company’s definition: Benefit expense ratio represents benefit expense as a percentage of premium revenue.
Source
| Period ended | Figure | Filing text |
|---|---|---|
| Sep 30, 2026 | 90.6% | The benefit expense ratio of 90.6 percent improved 70 basis points, driven by better performance in Medicare Advantage and Individual ACA compared to the prior year.8-K filed 2026-10-21 |
| Jun 30, 2026 | 89.7% | The benefit expense ratio of 89.7 percent increased 80 basis points year over year, driven by expected elevated medical cost trend in our Government businesses, partially offset by improved performance in Individual ACA compared to the prior year.8-K filed 2026-07-15 |
| Mar 31, 2026 | 86.8% | The benefit expense ratio was 86.8 percent, an increase of 40 basis points, reflecting expected elevated medical cost trend in our Medicaid business, partially offset by improved performance in Medicare.8-K filed 2026-04-22 |
| Dec 31, 2025 | 93.5% | The benefit expense ratio was 93.5 percent in the fourth quarter, an increase of 110 basis points compared to the prior year period, reflecting higher medical cost trend primarily in our Affordable Care Act health plans and heightened Medicare Part D seasonality driven by Inflation Reduction Act changes.8-K filed 2026-01-28 |
| Sep 30, 2025 | 91.3% | The benefit expense ratio was 91.3 percent, an increase of 180 basis points year over year, reflecting elevated, but expected, cost trend primarily in our Medicare business given pronounced seasonality in Part D benefits associated with changes made in the Inflation Reduction Act.8-K filed 2025-10-21 |
| Jun 30, 2025 | 88.9% | Benefit expense ratio2 · 89.7% · 88.9% · 88.3% · 87.7% · 80 bp3 · 60 bp310-Q filed 2026-07-15 |
Days in Claims Payable
44.9 at Sep 30, 2026
The filings read for this page do not define this measure.
| Period ended | Figure | Filing text |
|---|---|---|
| Sep 30, 2026 | 44.9 | Days in Claims Payable stood at 44.9 days as of September 30, 2026, an increase of 3.5 days year over year.8-K filed 2026-10-21 |
| Jun 30, 2026 | 45.4 | Days in Claims Payable stood at 45.4 days as of June 30, 2026, a decrease of 1.2 days from March 31, 2026 and an increase of 2.9 days year over year.8-K filed 2026-07-15 |
| Mar 31, 2026 | 46.6 | Days in Claims Payable stood at 46.6 days as of March 31, 2026, an increase of 5.3 days from December 31, 2025 and an increase of 3.8 days year over year.8-K filed 2026-04-22 |
| Dec 31, 2025 | 41.3 | Days in Claims Payable was 41.3 days as of December 31, 2025, a decrease of 0.1 days from September 30, 2025, and a decrease of 1.9 days compared to December 31, 2024.8-K filed 2026-01-28 |
| Sep 30, 2025 | 42.6 | Days in Claims Payable stood at 42.6 days as of September 30, 2025, when adjusted for our acquisition of CareBridge.8-K filed 2025-10-21 |
CarelonRx Quarterly Adjusted Scripts
82.6M for the period ended Sep 30, 2026
The filings read for this page do not define this measure.
| Period ended | Figure | Filing text |
|---|---|---|
| Sep 30, 2026 | 82.6M | CarelonRx Quarterly Adjusted Scripts · 82.6 · 85.0 · 80.9 · (2.8)% · 2.1%8-K filed 2026-10-21 |
| Jun 30, 2026 | 80.9M | CarelonRx Quarterly Adjusted Scripts · 80.9 · 83.3 · 80.3 · (2.9)% · 0.7%8-K filed 2026-07-15 |
| Mar 31, 2026 | 80.3M | CarelonRx Quarterly Adjusted Scripts · 80.3 · 83.9 · 88.5 · (4.3)% · (9.3)%8-K filed 2026-04-22 |
| Dec 31, 2025 | 88.5M | CarelonRx Quarterly Adjusted Scripts · 88.5 · 82.9 · 85.0 · 6.8% · 4.1%8-K filed 2026-01-28 |
| Sep 30, 2025 | 85M | CarelonRx Quarterly Adjusted Scripts · 85.0 · 80.2 · 83.3 · 6.0 % · 2.0 %8-K filed 2025-10-21 |
| Jun 30, 2025 | 83.3M | CarelonRx Quarterly Adjusted Scripts · 85.0 · 80.2 · 83.3 · 6.0 % · 2.0 %8-K filed 2025-10-21 |
| Mar 31, 2025 | 83.9M | CarelonRx Quarterly Adjusted Scripts · 80.3 · 83.9 · 88.5 · (4.3)% · (9.3)%8-K filed 2026-04-22 |
| Dec 31, 2024 | 82.9M | CarelonRx Quarterly Adjusted Scripts · 88.5 · 82.9 · 85.0 · 6.8% · 4.1%8-K filed 2026-01-28 |
Reading notes
Figures are shown as first reported. If a later filing prints a different figure for the same period, both appear. A figure marked ≈ or shown in words is how the company itself states it, not an estimate of ours. Companies change definitions over time, so compare periods with the quoted definition in mind. Periods that failed our checks are left out, so gaps are expected.
This page shows the latest 8 periods of each metric.